IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer

ABSTRACT:

SUBMITTER: Bilyard H 

PROVIDER: S-EPMC4288755 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature